Finance

Beta
Lists
CLOV:NASDAQ
Clover Health Investments Corp
$3.99
+9.32%
(+0.34) 1D
$3.97
-0.50% (-0.020)
After hours
Closed: Jun 4, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for CLOV...
Open
$3.65
High
$4.02
Low
$3.63
Mkt. cap
2.10B
Avg. vol.
7.52M
Volume
3.00
52-wk high
$4.23
52-wk low
$1.58
EPS
-$0.11
Beta
2.54
Shares outstanding
430.97M
No. of employees
724
Open
$3.65
High
$4.02
Low
$3.63
Mkt. cap
2.10B
Avg. vol.
7.52M
Volume
3.00
52-wk high
$4.23
52-wk low
$1.58
EPS
-$0.11
Beta
2.54
Shares outstanding
430.97M
No. of employees
724
Analyst outlook
Analyst Ratings
Based on 1 analyst giving stock ratings to CLOV in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12 month forecast
Based on 1 Wall Street analyst offering 12 month price targets for CLOV in the last 3 months.
Highest
Current $3.99
$4.20 (+5.26%)
Average
$4.20 (+5.26%)
Lowest
$4.20 (+5.26%)
News stories
From sources across the web
Profile
Clover Health Investments, Corp. is an American health care company founded in 2014. The company provides Medicare Advantage insurance plans and operates as a direct contracting entity with the U.S. government. The company manages care for Medicare beneficiaries in 11 states and started trading publicly on January 8, 2021. Wikipedia
About Clover Health Investments Corp
CEOAndrew Toy
Employees724
FoundedJul 17, 2014
HeadquartersJersey City, New Jersey, United States
SectorHealth care provider
Last report
May 6, 2026
Fiscal period
Q1 2026
EPS / Est. (USD)
$0.07 / $0.07
+6.57%beat
Revenue / Est. (USD)
749.19M / 725.70M
+3.24%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
477.62M
495.85M
487.71M
749.19M
Cost of goods sold
377.99M
423.47M
413.50M
589.65M
Cost of revenue
377.99M
423.47M
413.50M
589.65M
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
109.79M
97.15M
123.11M
131.69M
Operating expense
110.19M
96.75M
123.53M
132.21M
Total operating expenses
488.18M
520.23M
537.03M
721.86M
Operating income
-10.56M
-24.38M
-49.32M
27.33M
Other non operating income
-19.00K
-
-1.00K
-
EBT including unusual items
-10.58M
-24.38M
-49.32M
27.33M
EBT excluding unusual items
-10.58M
-24.38M
-49.32M
27.33M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-800.00K
-
-
Net income
-10.58M
-24.38M
-49.32M
27.33M
Net profit margin
-2.21%
-4.92%
-10.11%
3.65%
Earnings per share
0.03
0.00
-0.05
0.07
Interest and investment income
-
-
-
-
Interest expense
-
-
-
-
Net interest expenses
-
-
-
-
Depreciation and amortization charges
394.00K
406.00K
420.00K
515.00K
EBITDA
-10.16M
-23.97M
-48.90M
27.85M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more